Table 7 Univariate and multivariate analyses of prognostic factors for OS in patients with UGC

Age (≧75 vs < 75)

1.148

0.680–1.938

0.605

Gender (Female vs Male)

1.224

0.718–2.086

0.457

ECOG PS (1,2 vs 0)

2.203

1.372–3.537

0.001

BMI (< 18.0 vs ≧18.0)

1.401

0.864–2.271

0.172

SMI (Low vs High)

1.964

1.183–3.252

0.009

Histologic type (Differentiated vs Undifferentiated)

1.775

1.087–2.897

0.022

Peritoneum metastasis (Present vs Absent)

1.138

0.698–1.854

0.605

Lymph node metastasis (Present vs Absent)

1.019

0.642–1.618

0.936

Hematogenous metastasis (Present vs Absent)

1.101

0.675–1.793

0.702

Lines of chemotherapy (≧2nd line vs < 2nd line)

0.958

0.513–1.789

0.893

Lines of chemotherapy (≧3rd line vs <3rd line)

0.408

0.253–0.659

< 0.001

PNI (<  43.9 vs ≧43.9)

1.589

0.991–2.813

0.052

NLR (≧2.881 vs < 2.881)

2.071

1.297–3.307

0.002

CAR (≧0.077 vs < 0.077)

1.361

0.854–2.171

0.195

PLR (≧267 vs < 267)

1.490

0.885–2.510

0.134